Skip to main content

NCL To Pay $2M To Passenger Who Suffered a Heart Attack

NCL To Pay $2M To Passenger Who Suffered a Heart Attack

Introduction

A Trinidad and Tobago resident survived a heart attack onboard NCL's Norwegian Pearl vessel in 2016; however, his lawyers said he suffered unnecessary additional damages since he was kept on the ship for two days after the incident until the ship docked. His lawyers stated in a court document that the victim was assured by the ship personnel that the attack was a minor one, and it was okay to remain on the vessel till the ship docked; however, the ship did not speed up to get him there faster.

The ship docked in Miami on November 17, and the victim was taken to Mount Sinai Hospital where he was diagnosed with cardiogenic shock. He was implanted with four stents and kept on life support for five days. A jury found the NCL negligent and awarded the man $1.2 million for pain and suffering, loss of capacity for enjoyment; an additional $800,00 for future hospital and medical expenses; $84,000 for loss of past and future services.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

Appeals Court Upholds $611M Roundup Verdict

Categories: Roundup

A Missouri appeals court has upheld a massive Roundup verdict originally totaling $1.5 billion, but significantly reduced the final amount Bayer and its Monsanto unit must pay to $611 million.

The case involved three plaintiffs from New…

Valsartan “Wave 2” Bellwether Trial Schedule Set by Court

Categories: Valsartan

As the first Valsartan bellwether trial approaches in September 2025, the federal judge overseeing the multidistrict litigation (MDL) is preparing a second set of trials.

This move comes in anticipation of the possibility that parties may…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!